In humans, NAFLD is closely associated with obesity and insulin resistance, whereas in rodents, CDD results in profound hepatic steatosis without insulin resistance17,51 and MCDD causes an inflammatory steatohepatitis with fibrogenesis and significant weight loss with anincrease in peripheral insulin sensitivity30,52. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.